XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Awards Based on the closing market price of our common stock on September 30, 2023, the aggregate intrinsic value of our restricted stock awards was as follows:
   As of September 30,
2023		 
   Outstanding   Vested 
Aggregate intrinsic value  $5,632,476   $705,956 
Schedule of Restricted Stock Activity The following table summarizes the restricted stock activity for the Company’s directors and officers and employees of the Manager during the nine months ended September 30, 2023 and 2022.
   Nine months
ended
September 30,
2023		   Grant
Date Fair Value
per Share		 
Balance at December 31, 2022   80,984   $15.71 
Granted   323,452   $14.75 
Vested   (20,648)  $16.00 
Forfeited   (1,147)  $16.00 
Balance at September 30, 2023   382,641   $14.88 
   Nine months
ended
September 30,
2022		   Grant
Date Fair
Value
per Share		 
Balance at December 31, 2021   98,440   $16.00 
Vested   
-
   $16.00 
Forfeited   (13,438)  $16.00 
Unvested Balance at September 30, 2022   85,002   $16.00